Bond.az White LogoBond.az Black Logo

Tenable price target raised to $29

Stephens raised Tenable price target to $29, citing platform focus and AI opportunities. Tenable One adoption and new pricing are key catalysts.

Olivia Taylor
ByOlivia Taylor- Senior Editor
|
0

Stephens raised its price target on Tenable Holdings Inc. (NASDAQ:TENB) to $29 from $24, maintaining an Equal Weight rating. The firm highlighted Tenable's strategic focus on exposure management.

Tenable's investor meeting reinforced its platform vision, viewing AI as an opportunity rather than a disruptor. The growth strategy centers on driving adoption of Tenable One.

The company's platform strength is shown in its 78% gross profit margin. Increasing the Tenable One mix remains key to accelerating growth. Catalysts include migrating VM customers, new pricing, and Hexa AI remediation features.

Tenable's 2029 targets suggest growth acceleration will take time. Stephens believes accelerating growth is crucial for improving investor sentiment amid AI disruption concerns.

More News
Today / 12:35
|
248

BayCom Stock Rating Downgraded After Mgmt Changes

DA Davidson downgrades BayCom stock to Neutral after management changes. Find details on price target, dividend, and new leadership.

0
Today / 12:04
|
789

CoreWeave Stock: AI Infrastructure Demand

Deutsche Bank reaffirms Buy rating on CoreWeave amid AI infrastructure demand. Key financials and market insights.

0
Today / 12:01
|
683

PJM board letter positive for power producers

Melius Research sees PJM board letter as positive for independent power producers. Vistra shares up 16%, regulatory changes and market outlook.

0
Today / 11:03
|
631

Jefferies Raises SentinelOne Price Target to $24

Jefferies raised SentinelOne price target to $24 on margin outlook, maintaining Buy rating. Stock at $18.71, NNARR growth expected. Analyst sees H2 margin expansion.

0
Today / 11:02
|
566

ThinkEquity Initiates Atlas with Buy

ThinkEquity initiates Atlas Technical Consultants with a Buy rating and $15 target. The firm highlights the value of the Brazil critical-minerals option.

0
Today / 11:00
|
941

Reddit Stock Rating Boosted by App Growth

Citizens maintains Market Outperform on Reddit stock with $240 target. App installs surged 129% YoY, driving advertising growth.

0
Today / 10:33
|
492

Wolfe Research Reaffirms Ionis Stock Outperform Rating

Wolfe Research reiterates Outperform rating on Ionis Pharmaceuticals stock. Analysis of Arrowhead competition and financial results.

0
Today / 10:31
|
510

BTIG reiterates Uber Buy rating after Delivery Hero bid

BTIG reaffirms Uber Buy rating with $100 target after Delivery Hero bid. Stock seen as undervalued.

0
Today / 10:30
|
550

BTIG Reiterates Neutral on Affirm Stock

BTIG reiterates Neutral on Affirm stock amid credit trends. Analysis of delinquencies, growth prospects, and analyst targets.

0
Today / 10:02
|
707

Mizuho Cuts Intuit Target on TurboTax Weakness

Mizuho cuts Intuit target to $500 on TurboTax weakness; shares fall 20%. Read more on Bond.az.

0
Today / 08:00
|
677

Leerink Reaffirms Eli Lilly Stock Rating on Gene Therapy

Leerink reaffirms Eli Lilly stock rating with Outperform and $1,119 target, citing promising gene therapy data from VERVE-102 trial. Bond.az covers the latest.

0
Today / 06:02
|
602

Goldman Sachs Initiates Hemab Buy

Goldman Sachs initiates Hemab Therapeutics with buy rating. Sutacimig and HMB-002 target rare bleeding disorders.

0
...
Tenable price target raised to $29 | Bond.az